Israel · Delayed Price · Currency is ILS · Price in ILA BrainsWay Statistics
Total Valuation
BrainsWay has a market cap or net worth of ILS 994.27 million. The enterprise value is 783.33 million.
| Market Cap | 994.27M |
| Enterprise Value | 783.33M |
Important Dates
The last earnings date was Tuesday, November 11, 2025.
| Earnings Date | Nov 11, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
BrainsWay has 38.01 million shares outstanding. The number of shares has increased by 20.96% in one year.
| Current Share Class | 38.01M |
| Shares Outstanding | 38.01M |
| Shares Change (YoY) | +20.96% |
| Shares Change (QoQ) | -3.43% |
| Owned by Insiders (%) | 19.50% |
| Owned by Institutions (%) | 20.36% |
| Float | 23.27M |
Valuation Ratios
The trailing PE ratio is 61.78 and the forward PE ratio is 44.28.
| PE Ratio | 61.78 |
| Forward PE | 44.28 |
| PS Ratio | 6.12 |
| PB Ratio | 4.29 |
| P/TBV Ratio | 4.29 |
| P/FCF Ratio | 16.37 |
| P/OCF Ratio | 13.48 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 50.00, with an EV/FCF ratio of 12.90.
| EV / Earnings | 37.86 |
| EV / Sales | 4.82 |
| EV / EBITDA | 50.00 |
| EV / EBIT | 83.36 |
| EV / FCF | 12.90 |
Financial Position
The company has a current ratio of 3.19, with a Debt / Equity ratio of 0.10.
| Current Ratio | 3.19 |
| Quick Ratio | 2.91 |
| Debt / Equity | 0.10 |
| Debt / EBITDA | 1.43 |
| Debt / FCF | 0.37 |
| Interest Coverage | 1.54 |
Financial Efficiency
Return on equity (ROE) is 10.95% and return on invested capital (ROIC) is 2.94%.
| Return on Equity (ROE) | 10.95% |
| Return on Assets (ROA) | 1.92% |
| Return on Invested Capital (ROIC) | 2.94% |
| Return on Capital Employed (ROCE) | 3.26% |
| Revenue Per Employee | 1.35M |
| Profits Per Employee | 172,398 |
| Employee Count | 120 |
| Asset Turnover | 0.53 |
| Inventory Turnover | 3.04 |
Taxes
In the past 12 months, BrainsWay has paid 2.18 million in taxes.
| Income Tax | 2.18M |
| Effective Tax Rate | 9.51% |
Stock Price Statistics
The stock price has increased by +28.99% in the last 52 weeks. The beta is 0.25, so BrainsWay's price volatility has been lower than the market average.
| Beta (5Y) | 0.25 |
| 52-Week Price Change | +28.99% |
| 50-Day Moving Average | 2,629.50 |
| 200-Day Moving Average | 2,083.81 |
| Relative Strength Index (RSI) | 48.18 |
| Average Volume (20 Days) | 95,244 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BrainsWay had revenue of ILS 162.56 million and earned 20.69 million in profits. Earnings per share was 0.42.
| Revenue | 162.56M |
| Gross Profit | 121.78M |
| Operating Income | 9.40M |
| Pretax Income | 22.86M |
| Net Income | 20.69M |
| EBITDA | 14.07M |
| EBIT | 9.40M |
| Earnings Per Share (EPS) | 0.42 |
Balance Sheet
The company has 233.29 million in cash and 22.36 million in debt, giving a net cash position of 210.94 million or 5.55 per share.
| Cash & Cash Equivalents | 233.29M |
| Total Debt | 22.36M |
| Net Cash | 210.94M |
| Net Cash Per Share | 5.55 |
| Equity (Book Value) | 231.99M |
| Book Value Per Share | 5.93 |
| Working Capital | 188.53M |
Cash Flow
In the last 12 months, operating cash flow was 73.75 million and capital expenditures -13.02 million, giving a free cash flow of 60.73 million.
| Operating Cash Flow | 73.75M |
| Capital Expenditures | -13.02M |
| Free Cash Flow | 60.73M |
| FCF Per Share | 1.60 |
Margins
Gross margin is 74.92%, with operating and profit margins of 5.78% and 12.73%.
| Gross Margin | 74.92% |
| Operating Margin | 5.78% |
| Pretax Margin | 14.06% |
| Profit Margin | 12.73% |
| EBITDA Margin | 8.65% |
| EBIT Margin | 5.78% |
| FCF Margin | 37.36% |
Dividends & Yields
BrainsWay does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -20.96% |
| Shareholder Yield | -20.96% |
| Earnings Yield | 2.08% |
| FCF Yield | 6.11% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on May 22, 2011. It was a reverse split with a ratio of 0.25.
| Last Split Date | May 22, 2011 |
| Split Type | Reverse |
| Split Ratio | 0.25 |
Scores
BrainsWay has an Altman Z-Score of 2.82 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.82 |
| Piotroski F-Score | 5 |